These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS. SCHAFFNER F; KLION FM; LATUFF AJ Gastroenterology; 1965 Mar; 48():293-8. PubMed ID: 14292140 [No Abstract] [Full Text] [Related]
5. 20, 25-DIAZACHOLESTENOL DIHYDROCHLORIDE. INHIBITION OF CHOLESTEROL BIOSYNTHESIS IN HYPERLIPEMIC SUBJECTS. SACHS BA; WOLFMAN L Arch Intern Med; 1965 Sep; 116():366-72. PubMed ID: 14325910 [No Abstract] [Full Text] [Related]
6. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate. Evans RJ; Howard AN; Hyams DE Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031 [No Abstract] [Full Text] [Related]
7. The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine. VAN ITALLIE TB; HASHIM SA; CRAMPTON RS; TENNENT DM N Engl J Med; 1961 Sep; 265():469-74. PubMed ID: 13779996 [No Abstract] [Full Text] [Related]
8. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Denke MA; Grundy SM Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022 [TBL] [Abstract][Full Text] [Related]
9. MYOTONIA AND KERATODERMA INDUCED BY 20,25 DIAZACHOLESTENOL. ANDERSON PC; MARTT JM Arch Dermatol; 1965 Aug; 92():181-3. PubMed ID: 14314747 [No Abstract] [Full Text] [Related]
12. Hormonal hypercholesterolemia in the dog: influence of niacin, niacinamide, benzmalecene, and cholestyramine resin. ZANETTI ME; TENNENT DM Proc Soc Exp Biol Med; 1963 Apr; 112():991-5. PubMed ID: 14003205 [No Abstract] [Full Text] [Related]
13. CUTANEOUS EFFECTS OF HYPOCHOLESTEREMIC AGENTS. ROE DA N Y State J Med; 1964 Oct; 64():2559-63. PubMed ID: 14224225 [No Abstract] [Full Text] [Related]
15. EFFECT OF NICOTINIC ACID ON ABNORMAL SERUM LIPIDS. FITZGERALD O; HEFFERNAN A; BRENNAN P; MULCAHY R; FENNELLY JJ; MCFARLANE R Br Med J; 1964 Jan; 1(5376):157-9. PubMed ID: 14072652 [No Abstract] [Full Text] [Related]
16. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment]. Richter WO Fortschr Med; 1996 May; 114(14):177-8. PubMed ID: 8707237 [No Abstract] [Full Text] [Related]
17. Treatment of pruritus of obstructive jaundice with cholestyramine. DATTA DV; SHERLOCK S Br Med J; 1963 Jan; 1(5325):216-9. PubMed ID: 14025214 [No Abstract] [Full Text] [Related]
18. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition. Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607 [TBL] [Abstract][Full Text] [Related]
19. Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia. Turley SD; Daggy BP; Dietschy JM J Cardiovasc Pharmacol; 1996 Jan; 27(1):71-9. PubMed ID: 8656662 [TBL] [Abstract][Full Text] [Related]
20. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]